Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY26
Healthcare Equipment & Supplies
Medical Equipment & Supplies
143 Cr
Low Risk
37.6
60.5
0.1
2.2
206.00
102.00
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
3
Bullish
8
Bearish
27
Neutral
11
Bullish
8
Bearish
24
Neutral
8
Bullish
0
Bearish
24
Neutral
8
Bullish
0
Bearish
24
Neutral
8
Bullish
0
Bearish
24
Neutral
8
Bullish
0
View Standalone
View Standalone
Earkart Limited (EARKART) is currently trading at 104.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Earkart Limited is an integrated hearing healthcare company that manufactures and distributes digital hearing aids, accessories, and remote audiometry solutions, and operates a Shop-in-Shop (SIS) clinic network across India while supplying government programs through GeM and ALIMCO. The company reported FY26 revenue of ₹5,403.53 lakhs with EBITDA of ₹845.80 lakhs and PAT of ₹493.23 lakhs, but showed margin pressure versus prior year driven by higher expenditure and depreciation, while maintaining ROE of 11.72% and ROCE of 12.12%. Earkart’s core differentiated asset is the patented OMNI remote audiometer platform — a cloud-connected, tablet-based diagnostic and fitting system — which the company markets alongside four owned brands (EQFY, Fame, Radius, TINY) and leverages R&D, ISO 13485, CDSCO and BIS certifications. Government business is a strategic revenue anchor: 61% of FY26 sales came from government channels, reflecting multiple ALIMCO orders and GeM presence, while private and Shop-in-Shop expansion into Tier 2/3 cities underpins recurring diagnostic and conversion revenue. The company has initiated international expansion via a wholly-owned US subsidiary and showcased OMNI at major ENT conferences, signaling a deliberate management push to commercialize the connected audiometry platform globally and pursue selective inorganic and partnership-led growth.
Over the past 52 weeks, Earkart Limited has traded between a low of ₹102.00 and a high of ₹206.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Earkart Limited has a market capitalization of approximately 143.04. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Earkart Limited’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.64 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 143.04 Cr, Earkart Limited is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Earkart Limited operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Earkart Limited is 37.64. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.